Clinical Trials on Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line in Sweden
Total 2 results
-
Oslo University HospitalEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedQuality of Life | Cancer | Xerostomia | Adverse Effects | Late EffectsNorway, Netherlands, Sweden, Germany, United Kingdom, Greece, France, Israel, Italy, Poland
-
Sahar SalehiRecruiting